Chemours CO Form 4 insider transactions

Chemours Company director Courtney Mather acquired 2,226 deferred stock units, increasing total beneficial ownership to 6,216.3946 units.

A Chemours Company director has acquired 966 deferred stock units, increasing beneficial ownership to 3,280.0507 units.

Chemours Director Courtney Mather acquired 1,657 deferred stock units, increasing direct beneficial ownership to 3,960.9731 units, as part of a pre-arranged plan.

Gerardo Familiar Calderon, President of Advanced Performance Materials at Chemours Co, reported a routine disposition of shares for tax obligations.

Chemours' Chief Accounting Officer, David Will, reported a reduction in common stock holdings due to tax withholding on vested equity.

Denise Dignam, President and CEO of The Chemours Company, acquired 4,068 shares of common stock, increasing her beneficial ownership.

Chemours Company's CFO, Shane Hostetter, had 3,021 shares withheld to cover tax obligations related to vesting equity awards.

A Chemours Company executive reported the automatic withholding of shares to cover tax obligations related to vested equity awards.

A Chemours Company officer had 923 shares withheld to cover tax obligations related to vesting restricted stock units and dividend equivalent units.

Chemours CEO Denise Dignam's recent Form 4 filing details the withholding of 466 shares to cover tax obligations on vested equity awards.

A Chemours Company officer reported the automatic withholding of shares to cover tax obligations related to vested equity awards.

Chemours Company Director Courtney Mather has acquired 2,292 deferred stock units, equivalent to common stock, valued at $11.45 per unit.

Chemours Company Director Livingston Satterthwaite acquired 1,337 deferred stock units, equivalent to common stock, effective June 30, 2025, as part of a routine compensation grant.

Damian Gumpel, President of Titanium Technologies at The Chemours Company, acquired 21,222 shares of common stock across two transactions in early June 2025, increasing his total beneficial ownership to 131,701 shares.

Chemours Co's Chief Financial Officer, Shane Hostetter, recently purchased 4,450 shares of the company's common stock at a price of $11.28 per share.

Director Alister Cowan reports changes in beneficial ownership of Chemours Co stock, including acquisition of 14,096 shares and disposal of an unspecified amount.

Director Dawn L. Farrell reports changes in beneficial ownership of Chemours Co common stock, including acquisition of stock units and disposal of shares.

Director Pamela Fletcher reports acquisition of Chemours Co stock units and dividend equivalent units, increasing her beneficial ownership.

Director Erin N. Kane reports acquisition of Chemours Co stock units and dividend equivalent units.

Director Sean D. Keohane reports acquiring 14,096 stock units of Chemours Co, convertible to common stock upon separation from service, bringing total beneficial ownership to 63,872.1309 shares.

Director Livingston Satterthwaite reports acquiring 14,096 stock units of Chemours Co, convertible to common stock upon separation from service.

Director Joseph Daniel Kava reports changes in beneficial ownership of Chemours Co common stock, including acquisition of stock units and disposal of common stock.

Director Leslie M Turner reports acquisition of Chemours Co common stock and updates to beneficial ownership.

Director Mary B. Cranston reports acquiring 14,096 shares of Chemours Co common stock at $0 per share on April 22, 2025, bringing her total holdings to 100,539.8505 shares.

Director George R. Brokaw acquired 14,096 shares of Chemours Co through stock units that convert upon separation from service.

Director Courtney Mather acquired 14,096 shares of Chemours Co common stock on April 22, 2025, which will convert to common stock upon separation from service on the board.

Director Livingston Satterthwaite acquired deferred stock units equivalent to 970.0664 shares of Chemours Co common stock on March 31, 2025.

Chemours CEO Denise Dignam reports the acquisition of shares and stock options, including restricted stock units and options vesting over the next few years.

Diane I. Picho, Chief Enterprise Enablement Officer at Chemours Co, reports the acquisition of common stock and stock options.

Gerardo Familiar Calderon, a Chemours Co executive, acquired shares and stock options on March 3, 2025, according to a recent SEC filing.